Advertisement

Digestive Diseases and Sciences

, Volume 56, Issue 6, pp 1789–1793 | Cite as

Henoch–Schonlein Purpura Leads to Functional Gastrointestinal Disorders

  • Miguel Saps
  • Gati Dhroove
  • Ashish Chogle
Original Article

Abstract

Background

Pain predominant functional gastrointestinal disorders such as irritable bowel syndrome may develop as sequelae to acute infectious gastroenteritis. Henoch–Schonlein purpura is a vaculitis that causes an inflammatory insult to the intestinal mucosa.

Objective

To assess whether patients with Henoch–Schonlein purpura are more likely to develop functional gastrointestinal disorders in long-term follow-up than controls.

Patients and Methods

Families of children diagnosed with Henoch–Schonlein purpura from 2002 to 2009 were contacted at least 6 months after an acute episode. Parents completed a validated questionnaire to diagnose functional gastrointestinal disorders according to Rome III criteria.

Results

Thirty-eight patients (mean 9.9 years, range 3–22 years, 19 males) and 38 controls (mean 9.5 years, range 1–24 years, 21 males) were recruited. Of the patients, 81% had abdominal pain with Henoch–Schonlein purpura presentation. Initial abdominal pain had resolved in all cases. At the time of study, 60.5% patients and 2.6% controls had abdominal pain. Children in Henoch–Schonlein purpura group were diagnosed with various functional gastrointestinal disorders: Irritable bowel syndrome in 11%, functional abdominal pain syndrome in 8%, and functional abdominal pain in 2.8%. Steroid usage was associated with higher incidence of abdominal pain (87.5%) at the time of the study as compared to no steroid usage (40.9%), p = 0.0065.

Conclusions

Patients with Henoch–Schonlein purpura are at an increased risk of developing pain predominant functional gastrointestinal disorders. The presence of abdominal pain and use of steroids at presentation of Henoch–Schonlein purpura are associated with higher incidence of pain predominant functional gastrointestinal disorders.

Keywords

Henoch–Schonlein purpura Post-infectious functional gastrointestinal disorder Pain predominant functional gastrointestinal disorder Irritable bowel syndrome Functional abdominal pain Functional abdominal pain syndrome 

Abbreviations

HSP

Henoch–Schonlein purpura

QPGS

Questionnaire on Pediatric Gastrointestinal Symptoms

AP

Abdominal pain

FGID

Functional gastrointestinal disorder

PI-FGID

Post-infectious functional gastrointestinal disorder

PP-FGID

Pain predominant functional gastrointestinal disorder

IBS

Irritable bowel syndrome

FAP

Functional abdominal pain

FAPS

Functional abdominal pain syndrome

Notes

Conflict of interest

None.

References

  1. 1.
    Starfield B, Katz H, Gabriel A, et al. Morbidity in childhood—a longitudinal view. N Engl J Med. 1984;310:824–829.PubMedCrossRefGoogle Scholar
  2. 2.
    Saps M, Seshadri R, Sztainberg M, Schaffer G, Marshall BM, Di Lorenzo C. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr. 2008.Google Scholar
  3. 3.
    Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100:1868–1875.PubMedCrossRefGoogle Scholar
  4. 4.
    Crushell E, Rowland M, Doherty M, et al. Importance of parental conceptual model of illness in severe recurrent abdominal pain. Pediatrics. 2003;112:1368–1372.PubMedCrossRefGoogle Scholar
  5. 5.
    Drossman DA. Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol. 1996;22:252–254.PubMedCrossRefGoogle Scholar
  6. 6.
    Gwee KA. Irritable bowel syndrome: psychology, biology, and warfare between false dichotomies. Lancet. 1996;347:1267.PubMedCrossRefGoogle Scholar
  7. 7.
    Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–406.PubMedCrossRefGoogle Scholar
  8. 8.
    McKendrick MW, Read NW. Irritable bowel syndrome—post salmonella infection. J Infect. 1994;29:1–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997;314:779–782.PubMedGoogle Scholar
  10. 10.
    Parry SD, Stansfield R, Jelley D, et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol. 2003;98:1970–1975.PubMedGoogle Scholar
  11. 11.
    Parry SD, Stansfield R, Jelley D, et al. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol. 2003;98:327–331.PubMedCrossRefGoogle Scholar
  12. 12.
    Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999;318:565–566.PubMedGoogle Scholar
  13. 13.
    Saps M, Pensabene L, Di Martino L, et al. Post-infectious functional gastrointestinal disorders in children. J Pediatr. 2008;152:812–816. (6 e1).PubMedCrossRefGoogle Scholar
  14. 14.
    Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523–526.PubMedCrossRefGoogle Scholar
  15. 15.
    Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–811.PubMedCrossRefGoogle Scholar
  16. 16.
    Collins SM. Is the irritable gut an inflamed gut? Scand J Gastroenterol Suppl. 1992;192:102–105.PubMedCrossRefGoogle Scholar
  17. 17.
    Caplan A, Walker L, Rasquin A. Development and preliminary validation of the questionnaire on pediatric gastrointestinal symptoms to assess functional gastrointestinal disorders in children and adolescents. J Pediatr Gastroenterol Nutr. 2005;41:296–304.PubMedCrossRefGoogle Scholar
  18. 18.
    Caplan A, Walker L, Rasquin A. Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005;41:305–316.PubMedCrossRefGoogle Scholar
  19. 19.
    Gonzalez-Gay MA, Llorca J. Controversies on the use of corticosteroid therapy in children with Henoch–Schonlein purpura. Semin Arthritis Rheum. 2005;35:135–137.PubMedCrossRefGoogle Scholar
  20. 20.
    Huber AM, King J, McLaine P, Klassen T, Pothos M. A randomized, placebo-controlled trial of prednisone in early Henoch–Schonlein purpura [ISRCTN85109383]. BMC Med. 2004;2:7.PubMedCrossRefGoogle Scholar
  21. 21.
    Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch–Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241–247.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Pediatric Gastroenterology, Hepatology & Nutrition, Gastrointestinal Motility and Functional Bowel Disorders Program, Children’s Memorial HospitalNorthwestern UniversityChicagoUSA

Personalised recommendations